| Active substance |
Avanafil, Dapoxetine |
| Also known as |
TA-1790 |
| Blood pressure |
Can cause a decrease in blood pressure |
| Chemical name |
4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide |
| Dosage (medical) |
Typically 50 mg, 100 mg, or 200 mg tablets, taken as needed about 30 minutes before sexual activity |
| Dosage (sports) |
Not applicable |
| Effects |
Helps to achieve and maintain an erection |
| Formula |
C23H26ClN7O3 |
| Half-life |
Approximately 5 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Not specified |
| Main action |
Increases blood flow to particular areas of the body |
| Side effects |
Headache, flushing, nasal congestion, back pain, and dizziness |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Strength |
100/60 mg |
| Substance class |
PDE5 inhibitor |
| Trade name |
Stendra, Spedra |
| Use in sports |
Not typically used in sports |
| Water Retention |
No significant effect |
| Manufacturer |
Sunrise Remedies Pvt. Ltd. |
| Packing |
4 tabs/blister |
